trending Market Intelligence /marketintelligence/en/news-insights/trending/rPKzYflrUX4_yh7oFOQecw2 content esgSubNav
In This List

Intellia Therapeutics appoints president/CEO

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall

Blog

Insight Weekly: Dealmaking slumps; rate hikes hammer gold; transaction banking revenues jump

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future


Intellia Therapeutics appoints president/CEO

John Leonard will become Intellia Therapeutics Inc.'s president and CEO on Jan. 1, 2018.

Leonard succeeds Nessan Bermingham, the company's founding president and CEO.

Leonard was most recently the executive vice president of research and development at the genome editing company.